38 studies found for:    Amenorrhea: Clinical Trials
Show Display Options
Rank Status Study
1 Terminated A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea
Condition: Secondary Amenorrhea
Intervention: Drug: Progesterone
2 Completed A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
Condition: Amenorrhea
Interventions: Drug: DR-2021a;   Drug: DR-2021b;   Drug: DR-2021c;   Drug: DR-2021d;   Drug: DR-2021e;   Other: Placebo
3 Terminated
Has Results
The Luveris In Vitro Fertilization Trial
Conditions: Infertility;   Hypothalamic Amenorrhea;   Hyperprolactinemia
Interventions: Drug: Luveris fixed dose;   Drug: Luveris increasing dose
4 Recruiting Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
Conditions: Polycystic Ovary Syndrome;   Non-Alcoholic Fatty Liver Disease;   Metabolic Syndrome
Interventions: Drug: Metformin;   Drug: Placebo
5 Active, not recruiting Study of Leptin for the Treatment of Hypothalamic Amenorrhea
Condition: Amenorrhea
Interventions: Drug: r-metHuLeptin;   Drug: Oral Contraceptive Pills (OCPs)
6 Recruiting T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
Condition: Breast Cancer
Interventions: Drug: Trastuzumab;   Drug: Paclitaxel;   Drug: Trastuzumab emtansine
7 Completed Efficacy and Safety of Crosslinked Hyaluronan Gel for Preventing Intrauterine Adhesion
Condition: Intrauterine Adhesion
Interventions: Device: Crosslinked hyaluronic acid gel;   Device: Foleys balloon catheter
8 Active, not recruiting Analgesic Effect of Maternal Breast Milk Odor in Preterm Neonates: a Randomised Controlled Trial
Condition: Neonates Analgesy
Interventions: Other: maternal breast milk odor;   Other: no odor
9 Recruiting Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients
Condition: Breast Cancer Nos Premenopausal
Interventions: Drug: Docetaxel;   Drug: epirubicin;   Drug: cyclophosphamide;   Procedure: Modified radical mastectomy or breast-conserving Surgery;   Drug: Docetaxel (post-operative);   Drug: Epirubicin (post-operative);   Drug: Cyclophosphamide (post-operative);   Radiation: Radiation therapy;   Drug: Herceptin (post-operative);   Drug: Tamoxifen (post-operative)
10 Recruiting LutrePulse Hypogonadotropic Hypogonadism
Condition: Primary Amenorrhea With Hypogonadotropic Hypogonadism
Interventions: Drug: Gonadorelin acetate 10µg/pulse;   Drug: Gonadorelin acetate 15µg/pulse;   Drug: Gonadorelin acetate 20µg/pulse;   Drug: Placebo
11 Unknown  Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses
Condition: Gastroschisis
Intervention: Procedure: AMNIOECHANGE
12 Completed Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: adriamycin;   Drug: epirubicin;   Drug: fluorouracil
13 Completed Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
Conditions: Breast Cancer;   Osteoporosis
Interventions: Dietary Supplement: calcium carbonate;   Dietary Supplement: vitamin D;   Drug: risedronate sodium;   Other: placebo
14 Completed Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer
Conditions: Breast Cancer;   Infertility;   Menopausal Symptoms
Interventions: Drug: cyclophosphamide;   Drug: goserelin acetate;   Procedure: adjuvant therapy;   Procedure: fertility assessment and management;   Procedure: neoadjuvant therapy
15 Recruiting Anti-Mullerian Hormone Study. ICORG 10-16, V2
Conditions: Premenopausal Breast Cancer;   Breast Cancer
Intervention:
16 Active, not recruiting Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Ductal Breast Carcinoma In Situ;   HER2/Neu Positive
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Trastuzumab;   Radiation: Whole Breast Irradiation
17 Completed Effect of Hormone Replacement Therapy on Lupus Activity
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d
18 Completed
Has Results
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin
19 Terminated
Has Results
Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer
Conditions: Breast Cancer;   Hormone Changes;   Drug Toxicity
Intervention: Drug: triptorelin
20 Recruiting To Evaluate Effectiveness of Visanne in Improving Quality of Life in Asian Women With Endometriosis
Condition: Endometriosis
Intervention: Drug: Dienogest (Visanne, BAY86-5258)

   Previous Page Studies Shown (1-20) Next Page (21-38) Show next page of results    Last Page
Indicates status has not been verified in more than two years